Table 3. Annualized crude and standardized incidence rates (per 100,000 persons) of IPD by countries not using 7-valent pneumococcal conjugate vaccine*.
| Statistic or age group | Greenland (2000–2005) | Iceland (2000–2005) | Norway (2000–2005) | Northern Sweden (2003–2005) | Finland (2000–2005) |
|---|---|---|---|---|---|
| Total no. cases | 69 | 274 | 5,744 | 88 | 4,049 |
| Age-specific annualized incidence rates (no. cases) | |||||
| <2 y | 77.4 (8) | 89.8 (45) | 50.0 (355) | 21.1 (3) | 52.3 (367) |
| 2–19 y | 4.8 (5) | 6.8 (32) | 4.9 (312) | 0.0 (0) | 5.0 (346) |
| 20–64 y | 25.5 (53) | 8.9 (90) | 14.5 (2,352) | 9.3 (41) | 10.9 (2,057) |
| >65 y | 16.6 (3) | 53.1 (107) | 66.7 (2,725) | 30.9 (44) | 26.6 (1,279) |
| Crude annualized incidence (all ages) | 20.3 | 15.9 | 21.0 | 11.6 | 12.9 |
| Annualized age standardized incidence† | 19.8 | 14.6 | 16.2 | 9.1 | 11.6 |
*IPD, invasive pneumococcal disease, †Rates adjusted to 2000 World Health Organization world standard population estimates.